Esophageal cancer: This trial was completed on nine patients with advanced (stage IIIB/IV) esophageal cancer, four patients receiving a single and five receiving multiple doses of CAR T cells targeting MUC1 with PD-1 KO [256]. This evidence concerns the gene MUC1 and esophageal cancer.